Clinical Trials Browser

Phase 1 × Maximum Tolerated Dose × 1 year × Clear all

NCT05976555 2026-05-20

Phase I Trial of BCMA-TGF-BETA CAR-T Cells in Relapsed, Refractory Myeloma

Phase 1 Not yet recruiting

Multiple Myeloma

NCT06976892 2025-08-13

IDOL

Phase 1 Recruiting

Ovarian Neoplasms